Add BrightSurf on Google Email

Biomarker for COVID-19 risk

Researchers identified serum amyloid A (SAA) as a potential biomarker for COVID-19 risk, with higher levels associated with increased inflammation, clot abnormalities, and organ damage. This biomarker could help facilitate early identification of patients requiring aggressive management and monitoring.

SourceFlinders University·JournalInternational Journal of Infectious Diseases·DateApr 18, 2021

Child vaccination rates declined during COVID-19 pandemic

A Kaiser Permanente study found that child vaccination rates declined significantly during the COVID-19 pandemic, with measles vaccination coverage remaining substantially reduced in many age groups. The decline was more severe and persistent in older children, highlighting concerns about vaccine-preventable diseases.

SourceKaiser Permanente·JournalPEDIATRICS·DateApr 15, 2021

Narratives can help science counter misinformation on vaccines

Author Michael Dahlstrom's paper examines how narratives or storytelling can help counter misinformation on vaccines by providing context and connection between facts. This approach recognizes the disproportionate influence of narratives on attitudes and behaviors, and highlights their potential as a tool for public health education.

SourceIowa State University·JournalProceedings of the National Academy of Sciences·DateApr 13, 2021

COVID-19 vaccine prioritization

A survey study examines US adults' beliefs on who should be prioritized for access to COVID-19 vaccines. The study found that some groups, including young children and individuals with underlying health conditions, are more likely to be prioritized over others.

SourceJAMA Network·JournalJAMA Network Open·DateApr 9, 2021

COVID-19 news from Annals of Internal Medicine

Case report describes two patients who underwent a successful second dose of the Moderna vaccine using a graded dosing protocol after experiencing immediate hypersensitivity reactions. Both patients responded well and developed IgG antibodies, suggesting effective vaccination despite the modified dosing schedule.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·DateApr 5, 2021

Face masks associated with reducing healthcare workers' risk of acquiring COVID-19

Researchers found a correlation between Henry Ford's universal mask policy and a significant drop in the rate of healthcare workers testing positive for SARS-CoV-2. The study suggests that mask-wearing is effective in reducing the risk of acquiring COVID-19, supporting the institution's decision to implement the policy.

SourceHenry Ford Health·JournalJournal of Occupational and Environmental Medicine·DateMar 26, 2021

Snapshot of COVID-19 vaccine intentions highlights challenges of achieving community immunity goals

A recent study found that about half of Americans intend to get vaccinated as soon as possible, while others are hesitant or unlikely to get vaccinated. The survey highlights the need for targeted outreach to address vaccine hesitancy and build trust with communities, particularly among African American and Hispanic respondents.

Vaccine science and side effects: How news messages affect views on vaccination

A study by researchers at the Annenberg Public Policy Center found that news coverage of expert scientific evidence on vaccine safety increases public acceptance of vaccines. In contrast, personal narratives about real side effects diminish the positive effect of such messages. The experiment tested six video clips featuring experts an...

Partnership with churches increases COVID-19 vaccine delivery among Black population

A partnership between Loma Linda University and local churches has successfully vaccinated over 400 people in the predominantly Black community of San Bernardino County. The initiative, which included mobile vaccine clinics in church parking lots, resulted in an increase of 3.6% in Black attendance at mass vaccination clinics.

SourceLoma Linda University Adventist Health Sciences Center·JournalThe Lancet Global Health·DateMar 23, 2021

Pfizer vaccine less effective against S. African variant, Ben-Gurion U. study finds

Researchers at Ben-Gurion University found the Pfizer vaccine to be moderately less effective against the South African variant, while still providing protection against the British variant and the original strain. The study was published in Cell Host and Microbe and suggests that future variants may require a modified vaccine.